⭐ Recognized by FeedSpot: #12 Best Anesthesiology Blog Worldwide

Uncategorized Published - 16 August, 2018    By - Dr Clemens
Cesarean scar pregnancy and placenta accreta

This is very important to know if you do OB anesthesia. Ultrasound in Obstetrics & Gynecology April 2018 Author: D. Jurkovic MD Cesarean scar pregnancy is still considered a novel clinical entity, although the first reports describing its clinical presentation appeared nearly a quarter of a century ago1. It was recognized from the outset that […]

Read More
Uncategorized Published - 15 August, 2018    By - Dr Clemens
Fitch brightens its view on nonprofit hospitals

This is obviously very important to our specialty since most of us work in a hospital. Fitch Ratings said its “Rating Watch” for U.S. nonprofit hospitals and health systems is over after the organizations showed improved or stable results this year. During a six-month review of 125 existing issuers, Fitch affirmed 52% of the graded facilities […]

Read More
Uncategorized Published - 15 August, 2018    By - Dr Clemens
FDA approves TBI blood test that could reduce need for head CTs by 1/3

A blood test administered within 12 hours of a suspected traumatic brain injury (TBI) could help clinicians identify injuries like hemorrhage and contusion before having to resort to CT imaging, according to the preliminary results of a study published this week in the Lancet Neurology. Jeffrey Bazarian, MD, MPH, a co-leader of the paper and a professor at […]

Read More
Uncategorized Published - 15 August, 2018    By - Dr Clemens
A Case Report From the Anesthesia Incident Reporting System

ASA Monitor 8 2018, Vol.82, 48-49. Review of unusual patient care experiences is a cornerstone of medical education. Each month, the AQI-AIRS Steering Committee abstracts a patient history submitted to the Anesthesia Incident Reporting System (AIRS) and authors a discussion of the safety and human factors challenges involved. Real-life case histories often include multiple clinical decisions, […]

Read More
Uncategorized Published - 15 August, 2018    By - Dr Clemens
More Patients Getting Risky Steroid Injections for Back Pain as Opioids Become Less Available

Off-label, epidural use of Depo-Medrol (methylprednisolone acetate) injections for back pain is increasing as clinicians limit their opioid prescribing — but the treatment is risky and often ineffective — the New York Times reports. Depo-Medrol’s manufacturer, Pfizer, requested in 2013 that epidural use be banned owing to risks for blindness, paralysis, stroke, and death. The FDA declined […]

Read More